Bitcoin retreated from $70K while altcoins surged. Nvidia earnings beat expectations but shares faded. Analysis of crypto and stock market trends on Feb 26.
Browsing: News
Jane Street faces federal lawsuit over alleged insider trading in Terra Luna’s $40B collapse and separate ban from Indian markets over manipulation claims.
Bitcoin (BTC) surged 7% after Jane Street was sued over Terra’s collapse. Traders speculate the firm stopped its alleged daily 10 a.m. sell algorithm.
Microsoft (MSFT) stock jumped 2.5% on Starlink Kenya partnership news, 299M global connections, Xbox hardware teases, and Strong Buy analyst ratings.
Tempus AI (TEM) stock declines as JPMorgan slashes price target to $60. Q4 revenue surges 83% but profitability timeline remains unclear for investors.
Revolut explores 2026 share sale at $100B+ valuation before potential $150B IPO. The fintech begins testing a pound-pegged stablecoin with UK regulators.
Coinbase (COIN) stock surged 13% after introducing zero-commission stock and ETF trading with 24/5 availability for U.S. investors on February 24.
Intel (INTC) stock has surged 90% in a year to $46, trading at 112x earnings. EBITDA expected to reach $25.1B by 2028. Analysts divided on future outlook.
XWELL (XWEL) stock rallies 250% after revealing $31.3M private placement deal with American Ventures to repurchase debt and redeem preferred stock.
Axon Enterprise (AXON) stock jumped 18% after crushing Q4 earnings expectations with $797M revenue and strong 2026 guidance exceeding analyst projections.
RBC Capital Markets initiates AbbVie (ABBV) with outperform rating and $260 price target, citing Skyrizi/Rinvoq growth and undervalued EPS at 16x earnings.
GD Culture (GDC) stock climbs 7% after board approves selling Bitcoin from its 7,500 BTC reserve to finance a $100M buyback amid $344M unrealized loss.
Hut 8 (HUT) stock rises 2.4% despite Q4 loss of $301.8M from Bitcoin write-downs. Full-year revenue increased 45% to $235.1M with improving margins.
Recursion Pharmaceuticals (RXRX) stock rallies after beating Q4 estimates with -$0.21 EPS and $35.5M revenue, driven by Roche milestone payment.
GoDaddy (GDDY) stock crashed 16% after missing Q4 bookings estimates and issuing soft 2026 guidance. Analysts cut targets as AI concerns mount.